USPTO serial 99140228
HELIX
Reviewed by CopyMark Law Group
Status 748
- Filing date
- Status date
- Registration date
- —
- Examiner
- OROSS, JILLIAN E
- Law office
- TMO LAW OFFICE 134
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HELIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Mateo, CA, US
San Mateo, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DEVIN LEE JOSEPH LOOIJEN
400 S El Camino RealSuite 300San Mateo, CA 94402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic publications in the nature of reports and whitepapers in the field of artificial intelligence | ACTIVE | Mar 10, 2026 |
| 035 | Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of Artificial Intelligence (AI) | ACTIVE | Jun 24, 2024 |
| 041 | Non-downloadable electronic publications in the nature of reports and whitepapers in the field of artificial intelligence (AI); Providing online non-downloadable electronic publications in the nature of reports and whitepapers in the field of in the field of artificial intelligence (AI) relating to healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics | ACTIVE | Mar 10, 2026 |
| 042 | Research in the field of artificial intelligence (AI); Platform as a service (PAAS) featuring computer software platforms relating to storing, managing, analyzing, sharing, distributing, referencing, monitoring and integrating genetic information using Artificial Intelligence (AI); Scientific research consultancy in the field of artificial intelligence (AI) for genetics; Providing a website featuring non-downloadable software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of online non-downloadable chatbot software using large language models (LLMs) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence (AI) for analyzing genomic data, providing clinicogenomic and genomic insights, processing bioinformatics information, supporting genomic data interpretation, and facilitating genomic information analysis in the fields of healthcare, bioinformatics, medicine, diagnostics, population health, genomics, biotechnology support, precision medicine, and pharmacogenomics | ACTIVE | Nov 8, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Helix, Inc.
- Other trademarks owned by Helix, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named HELIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 30, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Sep 28, 2026 | IUAF | USE AMENDMENT FILED | — |
| Sep 28, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 29, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 28, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 28, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 28, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 25, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Oct 16, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 16, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 16, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 18, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 15, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 15, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 15, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 31, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 1, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 1, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 16, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 16, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2025 | NWAP | NEW APPLICATION ENTERED | — |